Treatment of the acute migraine attack;Die attackenbehandlung der migräne

Schmerz

Volumn 16, Issue 1, 2002, Pages 59-81

  Gobel H ^a,b   Heinze, A ^a  

^a Neurologisch Verhaltensmedizinische Schmerzklinik Kiel ^*  (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Acute therapy; Analgesics; Antiemetics; Migraine; Rules; Substances; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIEMETIC AGENT; BENZODIAZEPINE; CORTICOSTEROID; DIAZEPAM; DICLOFENAC; DIHYDROERGOTAMINE; DIMENHYDRINATE; DIPHENHYDRAMINE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; ELETRIPTAN; ERGOTAMINE; FROVATRIPTAN; IBUPROFEN; LYSINE ACETYLSALICYLATE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; PARACETAMOL; PREDNISOLONE; RIZATRIPTAN; ROFECOXIB; SEROTONIN AGONIST; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; UNINDEXED DRUG; ZOLMITRIPTAN; ERGOT ALKALOID;

AKINESIA; ALLERGIC ASTHMA; ANALGESIC NEPHROPATHY; ANGINA PECTORIS; BRONCHOSPASM; COMORBIDITY; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; GALACTORRHEA; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEADACHE; HEART PALPITATION; HUMAN; KIDNEY DISEASE; MENSTRUATION DISORDER; MIGRAINE; MIGRAINE AURA; NEUROLEPTIC MALIGNANT SYNDROME; PARESTHESIA; PARKINSONISM; PHOTODERMATOSIS; RAYNAUD PHENOMENON; REVIEW; REYE SYNDROME; RIGOR; SEROTONIN SYNDROME; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TACHYCARDIA; TINNITUS; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; TREMOR; VASCULITIS; VASOSPASM; ADOLESCENT; ADULT; AGE; CHILD; COMPARATIVE STUDY; EMERGENCY; INFANT; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; ANALGESICS; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; EMERGENCIES; ERGOT ALKALOIDS; HUMANS; INFANT; INFANT, NEWBORN; MIGRAINE DISORDERS;

EID: 19044392533     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-002-0135-4     Document Type: Review

References (49)

1. Allen C, Dayno J, Lines C, McCarroll K (2001) Rizatriptan wafer-sublingual vs. placebo at the onset of acute migraine. Cephalalgia 21(1):77
2. Bates D, Ashford E, Dawson R, Ensink FB, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P (1994) Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology 44(9):1587-1592
3. Bertin L, Brion N, Farkkila M, Gobel H, Wessely P (1999) A dose-defining study of sumatriptan suppositories in the acute treatment of migraine. Int J Clin Pract 53(8):593-598
4. Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K (1999) Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. Eur Neurol 42(3):173-179
5. Boureau F, Kappos L, Schoenen J, Esperanca P, Ashford E (2000) A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. Int J Clin Pract 54(5):281-286
6. Cabarrocas X, Esbri R, Peris F, Ferrer P (2001) Long-term efficacy and safety of oral almotriptan: interim analysis of a 1-year open study. Headache 41(1):57-62
7. Colman SS, Brod MI, Krishnamurthy A, Rowland CR, Jirgens KJ, Gomez-Mancilla B (2001) Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan. Clin Ther 23(1):127-145
8. Diener HC (1999) Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. Cephalalgia 19(6):581-588
9. Dowson A, Ball K, Haworth D (2000) Comparison of a fixed combination of domperidone and paracetamol (domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study. Curr Med Res Opin 16(3):190-197
10. 9a. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a metaanalysis of 53 trials. Lancet 358:1668-1675
11. Gallagher RM, Dennish G, Spierings EL, Chitra R (2000) A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache 40(2):119-128
12. Gnecchi-Ruscone T, Bernard X, Pierre P, Anderson D, Legg N, Enahoro H, Winter PD, Crisp A, Melin JA, Camici PG (2000) Effect of naratriptan on myocardial blood flow and coronary vasodilator reserve in migraineurs. Neurology 55(1):95-99
13. Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH (2000) Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology 54(1):156-163
14. Göbel H, Heinze A, Heinze-Kuhn K, Lindner V (2001) Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes. Headache 41(3):264-270
15. Göbel H, Heinze A, Stolze H, Heinze-Kuhn K, Lindner V (1999) Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Cephalalgia 19(7):676-683
16. Göbel H, Stolze H, Heinze A, Dworschak M (1996) Easy therapeutical management of sumatriptan-induced daily headache. Neurology 47:297-298
17. 15a. Göbel H (2002) Migräne und Kopfschmerzen. Springer Verlag Heidelberg, 3. Auflage
18. Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, Lines C (1998) Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache 38(10):737-747
19. Gruffyd-Jones K, Kies B, Middleton A, Mulder LJ, Rosjo OO, Millson DS (2001) Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. Eur J Neurol 8(3):237-245
20. Havanka H, Dahlof C, Pop PH, Diener HC, Winter P, Whitehouse H, Hassani H (2000) Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther 22(8):970-980
21. Jhee SS, Shiovitz T, Crawford AW, Cutler NR (2001) Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clin Pharmacokinet 40(3):189-205
22. Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, Wilkes K, Furey SA, Subramanian T, Cooper SA (2000) Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 20(4):233-243
23. Krymchantowski AV (2000) Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 58(2B):428-430
24. Lane PL, McLellan BA, Baggoley CJ (1989) Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 18(4):360-365
25. Lange R, Schwarz JA, Hohn M (2000) Acetylsalicylic acid effervescent 1000 mg (aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 20(7):663-667
26. Limmroth V, May A, Diener H (1999) Lysine-acetylsalicylic acid in acute migraine attacks. Eur Neurol 41(2):88-93
27. Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000) Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med 11-25(22):3486-3492
28. MacGregor EA, Wilkinson M, Bancroft K (1993) Domperidone plus paracetamol in the treatment of migraine. Cephalalgia 13(2):124-127
29. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR (1998) Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 98(1):25-30
30. Pascual J, Falk RM, Piessens F, Prusinski A, Docekal P, Robert M, Ferrer P, Luria X, Segarra R, Zayas JM (2000) Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study. Cephalalgia 20(6):588-596
31. Pascual J, Vega P, Diener HC, Allen C, Vrijens F, Patel K (2000) Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia 20(5):455-461
32. Pfaffenrath V, Cunin G, Sjonell G, Prendergast S (1998) Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache 38(3):184-190
33. Savani N, Pfaffenrath V, Rice L, Boswell D, Black L, Jones M (2001) Sumatriptan SUMB4007 Study Group. Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets. Clin Ther 23(2):260-271
34. Schwarzberg MN (1994) Application of metoclopramide specificity in migraine attacks therapy. Headache 34(7):439-441
35. Silberstein SD (1997) The pharmacology of ergotamine and dihydroergotamine. Headache 37 [suppl 1]:S15-S25
36. Spierings EL, Al-Shekhlee A, Reed R, Goadsby PJ, Ferrari MD, Stovner LJ, Senard JM, Jackson NC, Poole PH (2000) Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan, Neurology 55(5):735-742
37. Tfelt-Hansen P (1998) Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia 18(8):532-538
38. Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60(6):1259-1287
39. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G (1995) The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346 (8980):923-926
40. Tfelt-Hansen P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9-18
41. Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, Block GA, Reines SA, Visser WH (1998) Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache 38(10):748-755
42. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group (1991) Arandomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol 31(5):314-322
43. Tokola RA, Neuvonen PJ (1984) Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid. Br J Clin Pharmacol 17(1):67-75
44. Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bes A (1996) A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology 47(2):361-365
45. Treves TA, Streiffler M, Korczyn AD (1992) Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache 32(6):280-182
46. Visser WH, Jaspers NM, de Vriend RH, Ferrari MD (1996) Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgie 16(8):554-559
47. Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD (1996) Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group. Arch Neurol 53(11):1132-1137
48. Waelkens J (1982) Domperidone in the prevention of complete classical migraine. Br Med J (Clin Res Ed) 284(6320):944
49. Winner P, Ricalde O, Le Force B, Saper J, Margul B (1996) A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol 53(2):180-184